ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
M-retard Zentiva 200 mg, Retardtabletten - 30
53644007 Helvepharm AG
M-retard Zentiva 200 mg, Retardtabletten24.03.2000
  24.03.2000
Morphine (N02AA01)23.12.2005
WHO-DDD 
01.01.30.30
01.01.30. 
A+  
Yes 
IPCI
66.28No
    
10 %92.60
7680536440070Synthetika
  
Composition
morphini hydrochloridum trihydricum 200 mg corresp. morphinum 151.8 mg, lactosum monohydricum 164.4 mg, polyacrylatis dispersio 30 per centum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, ammonio methacrylatis copolymerum B, hypromellosum, magnesii stearas, Überzug: macrogolum 6000, talcum, hypromellosum, polyacrylatis dispersio 30 per centum, E 110 13.75 µg, E 124 22.5 µg pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Morphini Hydrochloridum Trihydricum200 mg correspond Morphine 151.8 mg
BAG: Active AgentDose
Morphini Hydrochloridum Trihydricum200 mg
 
Inactive agentsDoseadditional_information
Acidi Methacrylici  
Ammonio Methacrylatis Copolymerum B  
E 11013.75 µgcolor.
E 12422.5 µgcolor.
Ethylis Acrylatis Polymerisatum  
Hypromellosum  
Lactose Monohydrate164.4 mg 
Macrogol6000 Überzug
Magnesii Stearas  
Per Centum  
Polyacrylatis Dispersio30  
Pro Compresso Obducto  
Talcum  
 
Source
Data was imported : 04.02.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home